Leash Bio
Founded 2021 · 13 employees on LinkedIn · 1 known investors
Leash Bio builds a machine learning platform for drug discovery that generates proprietary protein-molecule interaction data to design and test novel chemical compounds. It develops new medicines, starting with two oncology targets, and partners with biopharma companies to explore molecule opportunities.
Investors · 1
Frequently asked questions
- What does Leash Bio do?
- Leash Bio builds a machine learning platform for drug discovery that generates proprietary protein-molecule interaction data to design and test novel chemical compounds. It develops new medicines, starting with two oncology targets, and partners with biopharma companies to explore molecule opportunities.
- Who are Leash Bio's investors?
- Leash Bio's investors include Metaplanet.